UT San Antonio
UT Health San Antonio
Category ID
26

Graduate School of Biomedical Sciences welcomes new PhD candidates

<p>As part of its 50th anniversary year celebrations, UT Health San Antonio’s Graduate School of Biomedical Sciences honored 46 PhD candidates in a white coat ceremony on Sept. 16, 2022. The milestone event honors those who passed their qualifying exams, transitioning from a PhD student to a PhD candidate.</p>

Share This Story

CPRIT awards $8 million for Greehey Children’s Cancer Research Institute core labs

<p>The Cancer Prevention &#038; Research Institute of Texas (CPRIT) has announced two awards totaling $8 million to support research infrastructure at UT Health San Antonio’s Greehey Children’s Cancer Research Institute, one of only two institutes in the U.S. dedicated solely to pediatric cancer research.</p>

Share This Story

Lowry Mays remembered for steadfast support of cancer patients

<p>Lowry Mays, who died Monday (Sept. 12, 2022), and his late wife, Peggy, were longtime supporters of the Mays Cancer Center, which is San Antonio’s only National Cancer Institute-Designated Cancer Center and one of four in Texas.</p>

Share This Story

School of Nursing professor’s SUD research gives hope to women and their families

<p>Lisa M. Cleveland, PhD, APRN, CPNP-PC, IBCLC, FAAN, professor in the School of Nursing at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a Certified Pediatric Nurse Practitioner and an International Board-Certified Lactation Consultant, whose career began in the Neonatal Intensive Care Unit (NICU), had dreamed of becoming a nurse for [&hellip;]</p>

Share This Story

Multimillion-dollar NIH grant to boost innovative ovarian cancer drug development

<p>The Mays Cancer Center at UT Health San Antonio and local partner Evestra Inc. have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health (NIH). It is the first grant of this kind awarded to UT Health San Antonio.</p>

Share This Story

San Antonio Combat PTSD Conference is back in person for 2022

<p>The 7th annual San Antonio Combat PTSD Conference, presented by the STRONG STAR Consortium and UT Health San Antonio, will resume an in-person format Oct. 26-27, 2022, at the Briscoe Western Art Museum along the San Antonio River Walk. Focal areas include resiliency enhancement, suicide prevention, research outcomes with next-generation PTSD treatments, advancing treatment of co-occurring conditions and implementation of evidence-based treatments in clinical settings.</p>

Share This Story

‘It’s like being able to see a dime on the surface of the moon.’

<p>UT Health San Antonio is investing $5 million over the next three years in cryo-electron microscopy (cryo-EM for short). The state-of-the-art technology adds a powerful new tool to solve disease riddles at the molecular level.</p>

Share This Story

Robotic kidney cancer surgery shows desirable outcomes in study

<p>In a study featured on the cover of the Journal of Urology (Official Journal of the American Urological Association), researchers from the Mays Cancer Center and Department of Urology show that robotically removing cancer from the inferior vena cava is a safe and effective alternative to the standard open surgery for kidney cancer.</p>

Share This Story

Announcing the inaugural dean for The University of Texas School of Public Health San Antonio

<p>We are delighted to announce the appointment of Vasan S. Ramachandran, MD, as the founding Dean of The University of Texas School of Public Health San Antonio, a strategic collaboration between UT Health San Antonio and The University of Texas at San Antonio (UTSA). Dr. Ramachandran serves currently as the Jay and Louise Coffman Professor [&hellip;]</p>

Share This Story

Molecular medicine associate professor receives UT System Rising STARs award

<p>Lingtao Jin, PhD from The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a UT System Rising STARs award in the amount of $250,000 to support his research into molecular-targeted therapies to treat human cancers.&nbsp; Jin is an associate professor in the Department of Molecular Medicine in the [&hellip;]</p>

Share This Story

Subscribe to Research